The IPOList

Blogs

Home

/

CHANDAN

Chandan Healthcare

Chandan Healthcare

CHANDAN

📅

Bidding Dates

10 Feb 2025 - 12 Feb 2025

💰

Price Range

₹151 - ₹159

🔢

Minimum Investment

₹1,27,200

📊

Issue Size

107Cr

💰

Latest GMP

₹5 (3.14%)

IPO Timeline

1

Issue open date

10 Feb 2025

2

Issue close date

12 Feb 2025

3

UPI mandate deadline

12 Feb 2025

4

Allotment finalization

13 Feb 2025

5

Refund initiation

14 Feb 2025

6

Share credit

14 Feb 2025

7

Listing date

17 Feb 2025

8

Mandate end date

25 Feb 2025

9

Lock-in end date for anchor investors (50%)

15 Mar 2025

10

Lock-in end date for anchor investors (remaining)

14 May 2025

About the Company

Chandan Healthcare operates a large diagnostic network in North India, with extensive pathology and radiology services across Jaipur, Uttar Pradesh, and Uttarakhand. As of December 31, 2024, the company has processed over 55.79 lakh tests from about 17.11 lakh patients, mainly generating 70.04% of its revenue from Uttar Pradesh. The network includes one flagship lab, nine central labs, and various accredited centres, offering 1,496 test types. Significant revenue streams come from B2B, B2G, and B2C segments, supported by a cluster-based model for efficiency. Additionally, its subsidiary, Chandan Pharmacy Limited, enhances revenue through sales of pharmaceuticals and FMCG across 31 stores.

Strengths

  1. Extensive diagnostic service network across North India.
  2. Holds NABL and NABH accreditations ensuring high quality standards.
  3. Strong market presence in Uttar Pradesh with significant revenue contributions.
  4. Diverse revenue streams from B2B, B2G, and B2C segments.
  5. Uses a cluster-based model for operational efficiency and market reach.

Risks

  1. High dependence on regional markets, particularly Uttar Pradesh, could pose economic risks.
  2. Regulatory changes may lead to increased compliance costs or operational restrictions.
  3. Management of an extensive facility network could impact financial stability.
  4. Legal and regulatory challenges could affect operational and financial conditions.
  5. Technological changes require continuous investment in advanced diagnostic technologies.

Grey Market Premium Trend

Made with ❤️ by Harsh Goel
Disclaimer: The content provided on theipolist.in is for educational and informational purposes only. We are not SEBI-registered advisors and are not involved in any grey market trades. Please consult with a registered financial advisor before making any investment decisions.